Cigarette Maker’s Coronavirus Vaccine Poised for Human Tests (1)

An experimental Covid-19 vaccine developed by cigarette maker British American Tobacco Plc is poised to begin testing in humans.

Pre-clinical tests of the vaccine showed a positive immune response, the London-based maker of Lucky Strike cigarettes said Friday in a statement. The first phase of human trials could begin as soon as late June if authorized by drug regulators, BAT said.

Read more: Coronavirus Vaccine Race Gets Unlikely Partner: Big Tobacco

Tobacco plants cultivated for vaccine development at the Kentucky BioProcessing facility.

Source: BAT

Drugmakers from around the world have jumped into the vaccine race, with more than 100 candidates in development in the U.S., Europe, China and other regions. BAT ...